Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Drugs & Therapy Perspectives
Published in: Drugs & Therapy Perspectives 1/2010

01-01-2010 | Practical Issues and Updates

News from the 38th European Symposium on Clinical Pharmacy; 3–6 November 2009; Geneva

Published in: Drugs & Therapy Perspectives | Issue 1/2010

Login to get access

Excerpt

On 3–6 November 2009, the European Society of Clinical Pharmacy (ESCP) and Swiss Society of Public Health Administration and Hospital Pharmacists (GSASA) jointly held the 38th European Symposium on Clinical Pharmacy in Geneva. The symposium on ‘30 years of Clinical Pharmacy: a Bright Future Ahead!’ focused on multidisciplinary cooperation, patient-focused care and integrating technology into clinical pharmacy, and was attended by >650 participants. This report highlights information from selected plenary lectures. …
Literature
1.
Laing R. Pricing of drugs and transparency in health care [evening plenary session]. 38th European Symposium on Clinical Pharmacy; 3–6 Nov 2009; Geneva
2.
Merrills J. Introduction to multidisciplanary care [plenary lecture 1]. 38th European Symposium on Clinical Pharmacy; 3–6 Nov 2009; Geneva
3.
Kinnear A, Mead G. Interdisciplanary perspectives on stroke treatment [plenary lecture 2]. 38th European Symposium on Clinical Pharmacy; 3–6 Nov 2009; Geneva
4.
Carollo A, Pascual M. Interdisciplanary perspectives on kidney transplant [plenary lecture 3]. 38th European Symposium on Clinical Pharmacy; 3–6 Nov 2009; Geneva
5.
Bergström R. How the drug industry wants to become more ethical [plenary lecture 4]. 38th European Symposium on Clinical Pharmacy; 3–6 Nov 2009; Geneva
6.
Hurst S. Dealing with prescribing ethics and conflict of interest. [plenary lecture 6]. 38th European Symposium on Clinical Pharmacy; 3–6 Nov 2009; Geneva
7.
Conen D. Communicating risk to patients [plenary lecture 10]. 38th European Symposium on Clinical Pharmacy; 3–6 Nov 2009; Geneva
8.
Weber C, Roten I, Marty S, et al. Electronic screening of inpatients’ medical records: a clinical decision support for physicians and clinical pharmacists? [poster PC-09]. 38th European Symposium on Clinical Pharmacy; 3–6 Nov 2009; Geneva
9.
Breguet C, Di Paolo ER, Verga J, et al. Evaluation of inhalation technique in asthmatic children visiting a specialised outpatient clinic [poster PT-33]. 38th European Symposium on Clinical Pharmacy; 3–6 Nov 2009; Geneva
Metadata
Title
News from the 38th European Symposium on Clinical Pharmacy; 3–6 November 2009; Geneva
Publication date
01-01-2010
Publisher
Springer International Publishing
Published in
Drugs & Therapy Perspectives / Issue 1/2010
Print ISSN: 1172-0360
Electronic ISSN: 1179-1977
DOI
https://doi.org/10.2165/11204070-000000000-00000

Other articles of this Issue 1/2010

Drugs & Therapy Perspectives 1/2010 Go to the issue

Drug and Profile Reports

Fesoterodine: a guide to its use in overactive bladder syndrome

Disease Management

Worldwide control of trachoma involves a strategy combining surgery, antibacterials, facial cleanliness and environmental improvements

Drug Reactions and Interactions

First reports of serious adverse drug reactions in recent weeks

Drug Reactions and Interactions

Glitazones accelerate bone loss and increase the risk of fracture in patients with type 2 diabetes mellitus

Disease Management

Aggressive treatment is essential to reduce cardiovascular risk in diabetic hypertensive patients

Disease Management

Antidepressants are the main options for the long-term pharmacological treatment of generalized anxiety disorder